-4-
more
First Quarter 2021 Conference Call Webcast
The Company will hold a conference call to discuss first-quarter 2021 financial
results today, beginning at 10:00 a.m.
Eastern time. Individual investors are invited to listen to the conference
call through Henry Schein’s website by visiting
www.henryschein.com/IRwebcasts
. In addition, a replay will be available beginning shortly
after the call has ended for a
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care
professionals powered by a network of
people and technology. With more than 20,000
Team Schein Members
worldwide, the Company's network of trusted
advisors provides more than 1 million customers globally with more
than 300 valued solutions that help improve operational
success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based
dental
and
medical
practitioners work more efficiently so they can provide quality care more effectively. These solutions also
support
dental laboratories
,
government and institutional health care clinics
, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution
network, with a selection of more than
120,000 branded products and Henry Schein private-brand products
in stock, as well as more than 180,000 additional
products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville,
N.Y.,
and has operations or affiliates in 31 countries and territories. The Company's sales reached
$10.1 billion in 2020, and
have grown at a compound annual rate of approximately 12 percent since Henry
Schein became a public company in 1995.
For more information, visit Henry Schein at
www.henryschein.com
,
Facebook.com/HenrySchein
,
and
@HenrySchein on Twitter
.
Cautionary Note Regarding Forward-Looking Statements and Use
of Non-GAAP Financial Information
In accordance with the “Safe Harbor” provisions of the Private Securities
Litigation Reform Act of 1995, we provide
the following cautionary remarks regarding important factors that,
among others, could cause future results to differ
materially from the forward-looking statements, expectations and assumptions
expressed or implied herein. All forward-
looking statements made by us are subject to risks and uncertainties and
are not guarantees of future performance.
These
forward-looking statements involve known and unknown risks, uncertainties
and other factors that may cause our actual
results, performance and achievements or industry results to be materially different
from any future results, performance or
achievements expressed or implied by such forward-looking statements. These
statements include EPS guidance and are
generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,”
“project,” “anticipate,” “to be,” “to make” or other comparable
terms.
A fuller discussion of our operations,
financial
condition and status of litigation matters, including factors that may
affect our business and future prospects, is contained in
documents we have filed with the United States Securities and Exchange
Commission, or SEC, including our Annual Report
on Form 10-K, and will be contained in all subsequent periodic filings
we make with the SEC. These documents identify in
detail important risk factors that could cause our actual performance to
differ materially from current expectations.
Forward
looking statements include the overall impact of the Novel Coronavirus Disease
2019 (COVID-19) on the Company, its
results of operations, liquidity, and financial condition (including any estimates of the impact on these items),
the rate and
consistency with which dental and other practices resume or maintain
normal operations in the United States and
internationally, expectations regarding personal protective equipment (“PPE”) and COVID-19 related product sales and
inventory levels and whether additional resurgences of the virus will adversely
impact the resumption of normal operations,